A. Beletsi

548 total citations
17 papers, 429 citations indexed

About

A. Beletsi is a scholar working on Economics and Econometrics, Biomaterials and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, A. Beletsi has authored 17 papers receiving a total of 429 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Economics and Econometrics, 4 papers in Biomaterials and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in A. Beletsi's work include Health Systems, Economic Evaluations, Quality of Life (7 papers), Nanoparticle-Based Drug Delivery (3 papers) and Economic and Financial Impacts of Cancer (3 papers). A. Beletsi is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (7 papers), Nanoparticle-Based Drug Delivery (3 papers) and Economic and Financial Impacts of Cancer (3 papers). A. Beletsi collaborates with scholars based in Greece and France. A. Beletsi's co-authors include Konstantinos Avgoustakis, Z. Panagi, Dionyssis S. Ithakissios, Evangelia Livaniou, Gregory P. Evangelatos, Pavlos Klepetsanis, E. Karampli, Elpida Pavi, Leondios Leondiadis and Georgia Kourlaba and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Biomedical Materials Research Part A and BMC Health Services Research.

In The Last Decade

A. Beletsi

15 papers receiving 417 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Beletsi Greece 8 236 135 122 108 46 17 429
Sarah Skidmore United States 9 315 1.3× 392 2.9× 115 0.9× 150 1.4× 64 1.4× 19 713
Justin Hadar United States 6 202 0.9× 239 1.8× 78 0.6× 97 0.9× 35 0.8× 9 447
Tracy K Pettinger United States 4 184 0.8× 75 0.6× 120 1.0× 148 1.4× 25 0.5× 5 400
Monica Ramchandani United States 8 109 0.5× 73 0.5× 47 0.4× 73 0.7× 16 0.3× 13 432
Z. Panagi Greece 9 193 0.8× 133 1.0× 130 1.1× 90 0.8× 38 0.8× 11 377
Matthieu Germain France 9 227 1.0× 37 0.3× 195 1.6× 262 2.4× 59 1.3× 15 567
Justin K. Y. Hong United States 11 109 0.5× 219 1.6× 206 1.7× 85 0.8× 29 0.6× 14 488
Silvana Mansueto Italy 5 69 0.3× 58 0.4× 48 0.4× 36 0.3× 14 0.3× 5 305
Blanka Halamoda‐Kenzaoui Italy 10 216 0.9× 44 0.3× 108 0.9× 182 1.7× 23 0.5× 11 487
Navid Mousazadeh Iran 13 196 0.8× 42 0.3× 136 1.1× 268 2.5× 65 1.4× 18 513

Countries citing papers authored by A. Beletsi

Since Specialization
Citations

This map shows the geographic impact of A. Beletsi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Beletsi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Beletsi more than expected).

Fields of papers citing papers by A. Beletsi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Beletsi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Beletsi. The network helps show where A. Beletsi may publish in the future.

Co-authorship network of co-authors of A. Beletsi

This figure shows the co-authorship network connecting the top 25 collaborators of A. Beletsi. A scholar is included among the top collaborators of A. Beletsi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Beletsi. A. Beletsi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
Gourzoulidis, George, et al.. (2022). Cost-Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece. Clinical Drug Investigation. 42(11). 999–1008.
3.
Gourzoulidis, George, M. Koulentaki, Antonis Kattamis, et al.. (2022). POSC76 Cost-Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece. Value in Health. 25(1). S101–S101. 1 indexed citations
4.
Gourzoulidis, George, Anna Koumarianou, Nikolaos Androulakis, et al.. (2021). Cost-effectiveness of trifluridine/tipiracil as a third-line treatment of metastatic gastric cancer, including adenocarcinoma of the gastrohesophageal junction, among patients previously treated in Greece. Expert Review of Pharmacoeconomics & Outcomes Research. 22(2). 259–269. 9 indexed citations
5.
6.
Stafylas, Panagiotis, et al.. (2019). PCV44 COST ANALYSIS OF THE INTRODUCTION OF A SINGLE-PILL COMBINATION OF ROSUVASTATIN AND EZETIMIBE IN THE GREEK SETTING. Value in Health. 22. S548–S548. 2 indexed citations
7.
Beletsi, A., et al.. (2018). Comparing Use of Health Technology Assessment in Pharmaceutical Policy among Earlier and More Recent Adopters in the European Union. Value in Health Regional Issues. 16. 81–91. 26 indexed citations
8.
Kourlaba, Georgia, George Gourzoulidis, George Andrikopoulos, et al.. (2016). Economic evaluation of trimetazidine in the management of chronic stable angina in Greece. BMC Health Services Research. 16(1). 520–520. 3 indexed citations
9.
Kourlaba, Georgia, et al.. (2015). Economic Evaluation Of Trimetazidine In The Management Of Chronic Stable Angina In Greece. Value in Health. 18(7). A391–A391. 1 indexed citations
10.
Kourlaba, Georgia, et al.. (2014). Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece. BMC Health Services Research. 14(1). 631–631. 13 indexed citations
11.
Kourlaba, Georgia, et al.. (2013). Economic Evaluation of Ivabradine in Chronic Heart Failure in Greece. Value in Health. 16(7). A524–A524. 1 indexed citations
12.
Beletsi, A., et al.. (2008). Simultaneous Optimization of Cisplatin-Loaded PLGA-mPEG Nanoparticles with Regard to their Size and Drug Encapsulation. Current Nanoscience. 4(2). 173–178. 3 indexed citations
13.
Panagi, Z., et al.. (2005). Immune responses in mice of β‐galactosidase adsorbed or encapsulated in poly(lactic acid) and poly(lactic‐co‐glycolic acid) microspheres. Journal of Biomedical Materials Research Part A. 73A(3). 332–338. 17 indexed citations
14.
Beletsi, A., Z. Panagi, & Konstantinos Avgoustakis. (2005). Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA–PEG diblock copolymers. International Journal of Pharmaceutics. 298(1). 233–241. 105 indexed citations
15.
Panagi, Z., et al.. (2004). PLA and PLGA microspheres of β‐galactosidase: Effect of formulation factors on protein antigenicity and immunogenicity. Journal of Biomedical Materials Research Part A. 70A(1). 139–148. 11 indexed citations
16.
Panagi, Z., A. Beletsi, Gregory P. Evangelatos, et al.. (2001). Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA–mPEG nanoparticles. International Journal of Pharmaceutics. 221(1-2). 143–152. 166 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sarah Skidmore Breakdown of academic impact, for papers by Justin Hadar Breakdown of academic impact, for papers by Tracy K Pettinger Breakdown of academic impact, for papers by Monica Ramchandani Breakdown of academic impact, for papers by Z. Panagi Breakdown of academic impact, for papers by Matthieu Germain Breakdown of academic impact, for papers by Justin K. Y. Hong Breakdown of academic impact, for papers by Silvana Mansueto Breakdown of academic impact, for papers by Blanka Halamoda‐Kenzaoui Breakdown of academic impact, for papers by Navid Mousazadeh
Rankless by CCL
2026